Dilated cardiomyopathy (DCM) is a condition where the heart’s main pumping chamber, the left ventricle, stretches and enlarges, becoming too weak to pump blood efficiently. It affects roughly 1 in 250 people and is the most common form of non-ischemic cardiomyopathy, meaning it isn’t caused by blocked coronary arteries. Over time, the heart compensates for its weakened pumping ability by stretching further, which ultimately makes the problem worse.
How the Heart Changes
In a healthy heart, the muscular walls of the left ventricle contract forcefully to push blood out to the body. In DCM, those walls thin out and the chamber balloons in size. The heart tries to maintain its output by relying on a basic mechanical principle: stretching the muscle fibers further so they snap back with more force, similar to pulling a rubber band back farther before releasing it. This works for a while, but eventually the muscle stretches beyond its ability to compensate.
The result is a heart that holds more blood than normal but can’t push enough of it forward with each beat. Pressure builds up inside the chamber, and fluid backs up into the lungs and body. A healthy left ventricle ejects about 55% to 70% of its blood with each contraction. In DCM, that percentage (called the ejection fraction) drops below 45%, and in many cases falls well below that threshold. This reduced pumping power is what drives the symptoms of heart failure.
What Causes It
DCM has dozens of potential causes, and in many cases more than one factor is involved. The causes generally fall into two categories: genetic and acquired.
Genetic Causes
A genetic origin can be identified in 20% to 35% of patients, particularly those with a family history of cardiomyopathy or sudden cardiac death at a young age. Over 60 genes have been linked to DCM. Some of these genes encode proteins that form the structural scaffolding of heart muscle cells, so mutations lead to weakened fibers that gradually fail under the constant workload of pumping blood.
Acquired Causes
Among non-genetic triggers, viral infections are one of the most common. Certain viruses can directly infect and inflame the heart muscle, a condition called myocarditis, which can progress to DCM if the damage is severe or ongoing. Coxsackievirus is a well-known culprit, and cytomegalovirus can drive chronic inflammation that leads to the same outcome. In Latin America, a parasitic infection called Chagas disease is the leading cause of non-ischemic cardiomyopathy.
Toxins also play a major role. Heavy alcohol use damages heart muscle cells through direct toxic effects and oxidative stress. Cocaine does the same. Certain chemotherapy drugs, particularly a class called anthracyclines, are known to cause heart muscle injury that can appear months or even years after treatment ends. Metabolic conditions round out the list: thyroid disorders (both overactive and underactive), diabetes, and low calcium levels can all alter how the heart muscle generates energy and contracts, eventually weakening it.
Symptoms and How They Progress
Many people with early DCM have no symptoms at all. The heart’s compensatory mechanisms can mask the problem for months or years. When symptoms do appear, they usually develop gradually, though in some cases they come on suddenly and severely.
The hallmark symptoms are shortness of breath (especially during activity or when lying flat), fatigue and weakness, and swelling in the feet and ankles from fluid retention. You may also notice a rapid or irregular heartbeat, chest pressure during exertion, loss of appetite, or a persistent cough. Waking up short of breath at night is a particularly telling sign, caused by fluid shifting into the lungs when you lie down.
As the condition progresses, these symptoms worsen. Activities that were once easy become exhausting. Fluid retention may spread from the ankles to the legs and abdomen. The irregular heartbeat can become more frequent and more noticeable.
How It’s Diagnosed
The primary diagnostic tool is an echocardiogram, an ultrasound of the heart. Doctors look for two things: an enlarged left ventricle and reduced pumping function. The formal diagnostic criteria require the ventricle to be dilated beyond a size threshold adjusted for your age and body surface area, combined with an ejection fraction below 45%. These measurements are typically taken using a technique that captures the heart from two angles to calculate volume accurately.
Crucially, the diagnosis also requires ruling out other explanations for the weakened heart. High blood pressure, significant valve disease, and coronary artery disease can all cause similar changes, and these must be excluded before DCM is diagnosed. This often means additional testing such as cardiac catheterization or cardiac MRI. Genetic testing may be recommended if there’s a family history of heart disease or sudden death.
Treatment
Treatment for DCM centers on slowing or reversing the heart’s decline and managing symptoms. Current guidelines from the American Heart Association and American College of Cardiology recommend four classes of medication as the foundation of therapy for people with reduced ejection fraction.
The first class works by blocking hormonal pathways that cause the heart and blood vessels to constrict, reducing the workload on the weakened heart. The second is beta blockers, which slow the heart rate and lower blood pressure, giving the heart more time to fill and reducing its oxygen demand. Three specific beta blockers have been proven to reduce mortality in heart failure. The third class blocks a hormone called aldosterone that promotes fluid retention and scarring in the heart. The fourth, originally developed for diabetes, reduces heart failure hospitalizations and cardiovascular death regardless of whether you have diabetes.
When medications alone aren’t enough, device-based therapies become an option. If your ejection fraction remains at or below 35% after at least three months of optimized medication, you may be a candidate for an implantable defibrillator. This small device monitors your heart rhythm continuously and delivers a corrective shock if a life-threatening arrhythmia occurs. For people whose heart’s electrical system has become uncoordinated (signaled by a widened pattern on an EKG), a specialized pacemaker can resynchronize the contractions of the left and right ventricles, improving efficiency.
In advanced cases that don’t respond to medications or devices, a mechanical pump can be implanted to assist the failing ventricle, or a heart transplant may be considered.
Complications to Watch For
DCM carries two serious complications beyond progressive heart failure. The first is abnormal heart rhythms. A stretched, weakened ventricle is electrically unstable, making it prone to dangerous rhythms that can cause sudden cardiac death. Atrial fibrillation, an irregular rhythm in the upper chambers, is also common and often goes undetected. In studies of heart failure patients, silent atrial fibrillation was found to be three times more common than episodes that cause noticeable symptoms.
The second major risk is blood clots and stroke. When the heart doesn’t empty fully, blood can pool and form clots, which may travel to the brain. The risk of ischemic stroke is five times higher in the first month after a heart failure diagnosis, based on data from a large population study in Rotterdam. This risk persists over time, which is why blood-thinning therapy is sometimes used even in patients without atrial fibrillation. In one major trial, blood thinners nearly halved the frequency of ischemic stroke in heart failure patients who had no detectable atrial fibrillation.
Long-Term Outlook
The prognosis for DCM varies widely depending on the cause, how early it’s caught, and how well treatment works. In a study tracking patients over 15 years, the survival rate was 44% at five years, 39% at ten years, and 34% at fifteen years. These numbers reflect a broad range of disease severity, and outcomes are generally better for people diagnosed early and treated aggressively with the full set of recommended medications.
Some forms of DCM are partially reversible. When the cause is identifiable and treatable (stopping alcohol use, treating a thyroid disorder, resolving a viral infection), the heart can sometimes recover significant function. Even in cases where the damage is permanent, consistent medication use and close follow-up can slow progression substantially and improve quality of life for years.